Advanced search
Publication Cover
HIV Clinical Trials Volume 7, 2006 - Issue 4
Submit an article Journal homepage
50
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Performance of Six Different Ritonavir-Boosted Protease Inhibitor–Based Regimens in Heavily Antiretroviral-Experienced HIV-Infected Patients

Carmen de MendozaDepartment of Infectious DiseasesHospital Carlos III, Madrid
,
Luisa ValerDepartment of Infectious DiseasesHospital Carlos III, Madrid
,
Esteve RiberaInfectious Diseases UnitHospital Vall d’Hebron, Barcelona, Spain
,
Pablo BarreiroDepartment of Infectious DiseasesHospital Carlos III, Madrid
,
Luz Martín-CarboneroDepartment of Infectious DiseasesHospital Carlos III, Madrid
,
German RamirezDepartment of Infectious DiseasesHospital Carlos III, Madrid
&
Vincent SorianoDepartment of Infectious DiseasesHospital Carlos III, MadridCorrespondence[email protected]
 show all
Pages 163-171 | Published online: 14 Jan 2015

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Pablo Rivas, Judit Morello, Carolina Garrido, Sonia Rodríguez-Nóvoa & Vincent Soriano. (2009) Role of atazanavir in the treatment of HIV infection. Therapeutics and Clinical Risk Management 5, pages 99-116.
Read now
Carmen de Mendoza, Judit Morelló, Pilar Garcia-Gascó, Sonia Rodríguez-Novoa & Vincent Soriano. (2007) Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients. Expert Opinion on Pharmacotherapy 8:6, pages 839-850.
Read now

Articles from other publishers (15)

. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 354 356 .
Atul K. PatelKetan K. Patel, Eknath Naik, Jingyi Duan, Rajiv Ranjan, Jagdish K. Patel & Hamisu M. Salihu. (2011) Comparison of the Effectiveness of Low-Dose Indinavir/Ritonavir (IDV/r)- versus Atazanavir/Ritonavir (ATV/r)-Based Generic Antiretroviral Therapy in NNRTI-Experienced HIV-1-Infected Patients in India. Journal of the International Association of Physicians in AIDS Care 10:2, pages 111-118.
Crossref
Julian H. Elliott. (2010) Second line antiretroviral therapy for treatment of HIV in Asia. Asian Biomedicine 4:5, pages 673-677.
Crossref
Eliza H Humphreys, Larry W Chang & Jamal Harris. (2010) Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy. Cochrane Database of Systematic Reviews.
Crossref
Roberto Zajdenverg, Thomas J Podsadecki, Sharlaa Badal-Faesen, Jaime Andrade-Villanueva, Joseph Gathe, Horacio Mingrone, Linda M Fredrick, Isabelle A Gaultier, W Chris Woodward & Barry M Bernstein. (2010) Similar Safety and Efficacy of Once- and Twice-Daily Lopinavir/Ritonavir Tablets in Treatment-Experienced HIV-1–Infected Subjects at 48 Weeks. JAIDS Journal of Acquired Immune Deficiency Syndromes 54:2, pages 143-151.
Crossref
. 2010. Meyler's Side Effects of Antimicrobial Drugs. Meyler's Side Effects of Antimicrobial Drugs 445 646 .
Eran Bendavid, Robin Wood, David A Katzenstein, Ahmed M Bayoumi & Douglas K Owens. (2009) Expanding Antiretroviral Options in Resource-Limited Settings-A Cost-Effectiveness Analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes 52:1, pages 106-113.
Crossref
O. Koch, S. Sheehy, R. Serafino & B.J. Angus. 2009. 477 494 .
Wolf Peter Hofmann, Vincent Soriano & Stefan Zeuzem. 2009. Antiviral Strategies. Antiviral Strategies 321 346 .
Esteban Ribera Pascuet & Adrià Curran. (2008) Utilidad clínica de atazanavir. Enfermedades Infecciosas y Microbiología Clínica 26, pages 55-67.
Crossref
Carmen De Mendoza, Carolina Garrido, Ana Treviño, Lourdes Anta, Eva Poveda & Vicente Soriano. (2008) Resistencia viral y barrera genética de atazanavir. Enfermedades Infecciosas y Microbiología Clínica 26, pages 28-33.
Crossref
Joaquín Portilla, Vicente Boix, Esperanza Merino & Sergio Reus. (2008) Atazanavir en terapias de rescate. Enfermedades Infecciosas y Microbiología Clínica 26, pages 22-27.
Crossref
Julian H Elliott, Lut Lynen, Alexandra Calmy, Andrea De Luca, Robert W Shafer, Maria Zolfo, Bonaventura Clotet, Sarah Huffam, Charles AB Boucher, David A Cooper & Jonathan M Schapiro. (2008) Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching. AIDS 22:16, pages 2053-2067.
Crossref
Barbara Vergani, Mirko Lo Cicero, Ottavia Vigano’, Francesca Sirianni, Stefania Ferramosca, Paola Vitiello, Paola Di Vincenzo, Maria Pia De Pasquale, Massimo Galli & Stefano Rusconi. (2008) Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir. Journal of Clinical Virology 41:2, pages 154-159.
Crossref
Carmen De MendozaCarolina GarridoAngelica CorralGerman Ramírez-OlivenciaInmaculada Jiménez-NacherNatalia ZahoneroJuan Gonzalez-LahozVincent Soriano. (2007) Changing Rates and Patterns of Drug Resistance Mutations in Antiretroviral-Experienced HIV-Infected Patients. AIDS Research and Human Retroviruses 23:7, pages 879-885.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.